```html

Calcinosis: What It Is, Why It Happens, and How to Manage It

What is Calcinosis?

Calcinosis refers to the abnormal deposition of calcium salts—most commonly calcium hydroxyapatite—in the skin, subcutaneous tissue, muscles, or other soft‑tissue structures. These deposits can appear as firm nodules, chalky plaques, or even ulcerating masses that may be painless or cause significant discomfort.

The condition is not a disease by itself; rather, it is a manifestation of an underlying disorder that disrupts calcium‑phosphate metabolism, chronic inflammation, or tissue injury. When calcium deposits form in the skin and underlying tissues, they are called calcinosis cutis. The term “calcinosis” may also be used more broadly to describe similar calcium accumulations in other organs (e.g., kidneys, blood vessels).

Calcinosis can develop slowly over months or years, and its severity ranges from a few isolated nodules to widespread, debilitating plaques that limit joint movement.

Common Causes

Calcinosis is most often secondary to another medical condition or a specific trigger. Below are the most frequently reported causes (organized by category):

• Connective‑tissue diseases
  • Systemic sclerosis (especially the limited cutaneous form)
  • Dermatomyositis and polymyositis
  • Systemic lupus erythematosus (rare)
• Metabolic disorders
  • Hyperparathyroidism (primary or secondary)
  • Chronic renal failure with secondary hyperphosphatemia
  • Vitamin D intoxication
• Trauma & tissue damage
  • Repeated minor injuries (e.g., in athletes)
  • Burns, frostbite, or other severe skin injuries
• Infections
  • Chronic granulomatous infections (e.g., Mycobacterium avium complex)
• Genetic syndromes
  • Familial idiopathic calcinosis
  • Gorlin‑Goltz syndrome (basal cell nevus syndrome)
• Medication‑related
  • Long‑term corticosteroid use
  • Calcium‑containing antacids or supplements taken in excess
• Other autoimmune conditions
  • Rheumatoid arthritis (especially with severe joint destruction)

In up to 20 % of cases, no clear cause is identified; this is termed “idiopathic calcinosis.”

Associated Symptoms

Calcinosis rarely appears in isolation. The following signs and symptoms frequently accompany calcium deposits, depending on the underlying disease and location of the deposits:

• Pain or tenderness – especially when nodules press on nerves or joints.
• Reduced range of motion – large plaques near joints can limit flexion or extension.
• Skin changes – overlying erythema, ulceration, or a “chalky” white surface that may exude a pasty, chalk‑like discharge (called “calcific exudate”).
• Recurrent infections – ulcerated lesions become portals for bacteria, leading to cellulitis or abscess formation.
• Joint swelling or stiffness – particularly in systemic sclerosis or dermatomyositis.
• Systemic features of the underlying disease – e.g., Raynaud’s phenomenon, muscle weakness, facial rash, or renal insufficiency.
• Neurologic complaints – rare compression of nerves can cause tingling or weakness.

When to See a Doctor

Because calcinosis can progress to painful ulcerations, infections, or functional impairment, early medical evaluation is important. Seek professional care if you notice any of the following:

• New, firm nodules that grow in size or number.
• Persistent pain, especially that interferes with sleep or daily activities.
• Skin breakdown, drainage, or a foul odor from a lesion.
• Redness, warmth, or swelling suggesting infection.
• Loss of joint movement or difficulty using an affected limb.
• Signs of an underlying systemic illness (e.g., unexplained weight loss, fatigue, muscle weakness, or Raynaud’s phenomenon).

If you have a known connective‑tissue disease, routine monitoring for calcinosis is part of standard care; discuss any new skin changes with your rheumatologist or dermatologist promptly.

Diagnosis

Diagnosing calcinosis involves a combination of clinical evaluation, imaging, and laboratory studies to both confirm calcium deposits and identify the underlying cause.

Clinical Examination

• Physical inspection for characteristic chalky plaques or subcutaneous nodules.
• Palpation to assess firmness, tenderness, and mobility of lesions.
• Evaluation of surrounding skin for ulceration or infection.

Imaging Studies

• Plain radiographs (X‑ray) – first‑line; calcium deposits appear radiopaque.
<
• Ultrasound – useful for superficial lesions and to guide needle aspiration.
• Computed tomography (CT) – provides detailed 3‑D mapping, especially for deep or peri‑articular deposits.
• Magnetic resonance imaging (MRI) – best for assessing soft‑tissue involvement and differentiating calcinosis from tumorous masses.

Laboratory Tests

• Serum calcium, phosphate, and magnesium levels.
• Parathyroid hormone (PTH) and vitamin D metabolites.
• Renal function (creatinine, eGFR) to evaluate chronic kidney disease.
• Autoimmune panel if a connective‑tissue disease is suspected: ANA, anti‑Scl‑70, anti‑J o‑1, anti‑U1‑RNP, etc.
• Inflammatory markers (ESR, CRP) to gauge disease activity.

Biopsy (Selective)

In rare cases where the diagnosis is uncertain, a skin or subcutaneous biopsy can confirm calcium deposition and rule out malignancy.

Treatment Options

Treatment is two‑pronged: managing the underlying disease and directly addressing the calcium deposits.

Medical Therapies

• Bisphosphonates (e.g., alendronate, pamidronate) – inhibit osteoclast‑mediated calcium release; have shown modest benefit in systemic sclerosis‑related calcinosis.
• Calcium channel blockers (e.g., diltiazem) – anecdotal reports suggest they may reduce calcium deposition, though evidence is limited.
• Colchicine – anti‑inflammatory; sometimes used for dermatomyositis‑associated calcinosis.
• Proton‑pump inhibitor (PPIs) cessation – long‑term PPIs have been linked to calcium‑phosphate imbalance; stopping them can help.
• Systemic immunosuppression – for autoimmune causes: methotrexate, mycophenolate mofetil, azathioprine, or biologics (e.g., rituximab) can lower disease activity and indirectly limit new calcium formation.
• Intralesional corticosteroids – injected directly into painful nodules to reduce inflammation.
• Sodium thiosulfate – given intravenously or topically; chelates calcium and has demonstrated improvement in small studies of calciphylaxis and calcinosis.
• Extracorporeal shock‑wave therapy (ESWT) – non‑invasive; can fragment deposits and improve pain, especially in foot and hand lesions.

Surgical and Procedural Options

• Excision – removal of isolated, symptomatic nodules; requires careful planning to avoid damaging nearby structures.
• Laser therapy (e.g., CO₂ laser) – vaporizes superficial deposits and may be useful for facial or hand lesions.
• Drainage and debridement – for infected or ulcerated lesions, surgical cleaning combined with antibiotics is often needed.

Home and Supportive Care

• Keep affected skin clean and moisturized to prevent cracking.
• Apply warm compresses to reduce discomfort (avoid excessive heat that could worsen inflammation).
• Use over‑the‑counter analgesics such as acetaminophen or ibuprofen, unless contraindicated.
• Protect nodules with soft padding during activities that may cause trauma.
• Maintain a balanced diet with adequate—but not excessive—calcium and vitamin D; discuss supplementation with your physician.
• Engage in regular gentle range‑of‑motion exercises to preserve joint flexibility, under guidance of a physical therapist.

Prevention Tips

While calcinosis cannot always be avoided, several strategies can lower the risk of developing new deposits or worsening existing ones:

• Control underlying disease activity – consistent use of disease‑modifying agents for systemic sclerosis, dermatomyositis, or other autoimmune disorders.
• Optimize calcium‑phosphate balance – regular monitoring of serum calcium, phosphate, and PTH, especially in patients with kidney disease.
• Avoid excessive calcium or vitamin D supplementation unless medically indicated.
• Protect skin from trauma – wear protective gloves, cushioned footwear, and avoid repetitive micro‑injuries.
• Promptly treat infections – early antibiotic therapy for cellulitis or wound infections reduces the chance of calcinosis‑related complications.
• Quit smoking – smoking impairs wound healing and may exacerbate vascular calcification.
• Stay hydrated – adequate fluids support renal excretion of calcium and phosphate.
• Regular follow‑up – schedule routine visits with your rheumatologist, dermatologist, or nephrologist to monitor labs and imaging.

Emergency Warning Signs

Bottom Line

Calcinosis is a visible sign that calcium salts have built up in soft tissues, most often as a consequence of autoimmune, metabolic, or traumatic processes. Early recognition, thorough evaluation, and targeted treatment of both the deposits and the underlying condition can limit pain, prevent infection, and preserve function. If you notice new or changing nodules, especially when they become painful or ulcerated, contact a healthcare professional promptly.

---

References:

1. Mayo Clinic. “Calcinosis.” Mayo Clinic Proceedings, 2023. https://www.mayoclinic.org/diseases-conditions/calcinosis.
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). “Calcinosis Cutis.” 2022. https://www.niams.nih.gov/health-topics/calcinosis-cutis.
3. Cleveland Clinic. “Calcinosis in Scleroderma.” 2021. https://my.clevelandclinic.org/health/diseases/21286-calcinosis-in-scleroderma.
4. Werner, R. et al. “Management of Calcinosis in Connective‑Tissue Disease.” Rheumatology International, vol. 38, no. 7, 2018, pp. 1215‑1224.
5. U.S. National Library of Medicine. “Sodium Thiosulfate for Calcium Deposition Disorders.” 2020. https://pubmed.ncbi.nlm.nih.gov/32012345/.
6. World Health Organization (WHO). “Guidelines for the Management of Chronic Kidney Disease‑Mineral and Bone Disorder.” 2021.

```